Aldeyra Therapeu (ALDX)

$5.17 -0.05 (-0.96%)
Market Cap 312.66M
Revenue (ttm) 0.00
Net Income (ttm) -55.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.24
Volume 606,500
Avg Vol 1,080,638
Day's Range N/A - N/A
Shares Out 59.90M
Stochastic %K 82%
Beta 0.76
Analysts Strong Sell
Price Target $8.20

Company Profile

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator th...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 761 4904
Fax: 339 674 6495
Address:
131 Hartwell Avenue, Suite 320, Lexington, United States
PeterV9764
PeterV9764 Aug. 7 at 11:28 PM
$ALDX No shares sold …
1 · Reply
All4Retiring
All4Retiring Aug. 7 at 8:09 PM
$ALDX quarterly report for Aldeyra on the IR website Form 10-Q Filing Date August 7, 2025 Document Date June 30, 2025 Form Description Quarterly report which provides a continuing view of a company's financial position Filing Group Quarterly Filings Company Aldeyra Therapeutics, Inc. Issuer ALDEYRA THERAPEUTICS, INC.
0 · Reply
ktrader1991
ktrader1991 Aug. 7 at 5:41 PM
$ALDX we need the other 2 phase 2 trials to be released and successful. Come on Todd bring her home.
1 · Reply
Moneymachineuser
Moneymachineuser Aug. 7 at 3:34 PM
$ALDX completely normal today, buy the dip! ☺️
0 · Reply
All4Retiring
All4Retiring Aug. 7 at 2:01 PM
$ALDX FYI https://www.ladbible.com/news/world-news/chikungunya-virus-china-outbreak-134428-20250805
1 · Reply
Bigbas
Bigbas Aug. 7 at 12:43 PM
$ALDX LEG DAY!!!
1 · Reply
TampaTony
TampaTony Aug. 6 at 8:22 PM
$ALDX Montana, any 25k buys today?
1 · Reply
MontanaT
MontanaT Aug. 6 at 4:55 PM
$ALDX
0 · Reply
MontanaT
MontanaT Aug. 6 at 4:52 PM
$ALDX
0 · Reply
Moneymachineuser
Moneymachineuser Aug. 6 at 3:59 PM
$ALDX 1400 shares added today, wishing everyone the best here!!!😇
0 · Reply
Latest News on ALDX
Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Aug 6, 2025, 7:01 AM EDT - 1 day ago

Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Inherited Retinal Dystrophies including Retinitis Pigmentosa

Jul 24, 2025, 7:00 AM EDT - 14 days ago

Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Inherited Retinal Dystrophies including Retinitis Pigmentosa

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease

Jul 17, 2025, 7:00 AM EDT - 21 days ago

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease

Aldeyra Therapeutics: Pivotal FDA Decision After Reproxalap's Chamber Data

Jul 2, 2025, 9:23 PM EDT - 5 weeks ago

Aldeyra Therapeutics: Pivotal FDA Decision After Reproxalap's Chamber Data

Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma

Jun 26, 2025, 7:00 AM EDT - 6 weeks ago

Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

Jun 17, 2025, 7:00 AM EDT - 7 weeks ago

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference

May 29, 2025, 7:01 AM EDT - 2 months ago

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference

ALDX INVESTIGATION NOTICE: Aldeyra Therapeutics, Inc. Investors are Notified of the Pending Securities Investigation; Contact BFA Law

May 7, 2025, 4:07 PM EDT - 3 months ago

ALDX INVESTIGATION NOTICE: Aldeyra Therapeutics, Inc. Investors are Notified of the Pending Securities Investigation; Contact BFA Law

ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with Losses may have been affected by Securities Violations – Contact BFA Law (NASDAQ:ALDX)

May 7, 2025, 8:46 AM EDT - 3 months ago

ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with Losses may have been affected by Securities Violations – Contact BFA Law (NASDAQ:ALDX)

Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter – Hagens Berman

May 6, 2025, 4:42 PM EDT - 3 months ago

Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA's Reproxalap Complete Response Letter – Hagens Berman

ALDX SECURITIES NEWS: Aldeyra Therapeutics, Inc. Investigation Could Allow Investors to Recover Losses; Contact BFA Law to Discuss

May 6, 2025, 3:48 PM EDT - 3 months ago

ALDX SECURITIES NEWS: Aldeyra Therapeutics, Inc. Investigation Could Allow Investors to Recover Losses; Contact BFA Law to Discuss

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission

May 5, 2025, 6:34 PM EDT - 3 months ago

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap

May 5, 2025, 4:00 PM EDT - 3 months ago

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap

ALDX SECURITIES NOTICE: Suffer Losses on Aldeyra Therapeutics, Inc.? Investors are Alerted to Contact BFA Law about its Continuing Investigation

May 5, 2025, 3:38 PM EDT - 3 months ago

ALDX SECURITIES NOTICE: Suffer Losses on Aldeyra Therapeutics, Inc.? Investors are Alerted to Contact BFA Law about its Continuing Investigation

ALDX INQUIRY NOTICE: Aldeyra Therapeutics (NASDAQ:ALDX) Investors may have been affected by Securities Violations -- Contact BFA Law

May 3, 2025, 7:18 AM EDT - 3 months ago

ALDX INQUIRY NOTICE: Aldeyra Therapeutics (NASDAQ:ALDX) Investors may have been affected by Securities Violations -- Contact BFA Law

ALDX INVESTIGATION: Aldeyra Therapeutics (NASDAQ:ALDX) Investors with Losses are Urged to Contact BFA Law about its Investigation into the Company

May 1, 2025, 8:08 AM EDT - 3 months ago

ALDX INVESTIGATION: Aldeyra Therapeutics (NASDAQ:ALDX) Investors with Losses are Urged to Contact BFA Law about its Investigation into the Company

ALDX ANNOUNCEMENT: Aldeyra Therapeutics, Inc. Investors may have been affected by Securities Violations - Contact BFA Law

Apr 30, 2025, 3:38 PM EDT - 3 months ago

ALDX ANNOUNCEMENT: Aldeyra Therapeutics, Inc. Investors may have been affected by Securities Violations - Contact BFA Law

ALDX NEWS: Aldeyra Therapeutics, Inc. is Being Investigated for Securities Violations - Investors are Alerted to Contact BFA Law

Apr 29, 2025, 4:07 PM EDT - 3 months ago

ALDX NEWS: Aldeyra Therapeutics, Inc. is Being Investigated for Securities Violations - Investors are Alerted to Contact BFA Law

ALDX Investors Have Opportunity to Join Aldeyra Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Apr 29, 2025, 9:49 AM EDT - 3 months ago

ALDX Investors Have Opportunity to Join Aldeyra Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Bragar Eagel & Squire, P.C. Is Investigating TechTarget and Aldeyra and Encourages Investors to Contact the Firm

Apr 28, 2025, 9:00 PM EDT - 3 months ago

Bragar Eagel & Squire, P.C. Is Investigating TechTarget and Aldeyra and Encourages Investors to Contact the Firm

TTGT

ALDX NOTICE: Aldeyra Therapeutics, Inc. Investors are Notified of Pending Securities Investigation - Contact BFA Law if You Lost Money

Apr 28, 2025, 3:46 PM EDT - 3 months ago

ALDX NOTICE: Aldeyra Therapeutics, Inc. Investors are Notified of Pending Securities Investigation - Contact BFA Law if You Lost Money

ALDX SHAREHOLDER REVIEW: Aldeyra Therapeutics (NASDAQ:ALDX) is being Investigated after 75% Stock Drop – Investors are Urged to Contact BFA Law

Apr 27, 2025, 8:20 AM EDT - 3 months ago

ALDX SHAREHOLDER REVIEW: Aldeyra Therapeutics (NASDAQ:ALDX) is being Investigated after 75% Stock Drop – Investors are Urged to Contact BFA Law

ALDX SHAREHOLDER NEWS: Aldeyra Therapeutics, Inc. 75% Stock Plummet Leads to Securities Investigation - Investors are Urged to Contact BFA Law

Apr 25, 2025, 3:22 PM EDT - 3 months ago

ALDX SHAREHOLDER NEWS: Aldeyra Therapeutics, Inc. 75% Stock Plummet Leads to Securities Investigation - Investors are Urged to Contact BFA Law

ALDX SHAREHOLDERS: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) 75% Stock Drop Triggers Investigation – Contact BFA Law if You Lost Money

Apr 25, 2025, 7:36 AM EDT - 3 months ago

ALDX SHAREHOLDERS: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) 75% Stock Drop Triggers Investigation – Contact BFA Law if You Lost Money

ALDX NOTICE: A Securities Investigation was initiated on behalf of Aldeyra Therapeutics, Inc. Investors - Contact BFA Law

Apr 24, 2025, 3:18 PM EDT - 3 months ago

ALDX NOTICE: A Securities Investigation was initiated on behalf of Aldeyra Therapeutics, Inc. Investors - Contact BFA Law

ALDX INVESTIGATION: Aldeyra Therapeutics, Inc. is being Investigated for Securities Violations - Investors are Notified to Contact BFA Law

Apr 23, 2025, 3:36 PM EDT - 3 months ago

ALDX INVESTIGATION: Aldeyra Therapeutics, Inc. is being Investigated for Securities Violations - Investors are Notified to Contact BFA Law

LEGAL NOTICE: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Investors are Notified of the Pending Securities Investigation - Contact BFA Law

Apr 23, 2025, 8:18 AM EDT - 3 months ago

LEGAL NOTICE: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Investors are Notified of the Pending Securities Investigation - Contact BFA Law

ALDX LEGAL NEWS: BFA Law Announces that Aldeyra Therapeutics, Inc. is being Investigated - Contact the Firm if You Lost Money

Apr 22, 2025, 3:23 PM EDT - 3 months ago

ALDX LEGAL NEWS: BFA Law Announces that Aldeyra Therapeutics, Inc. is being Investigated - Contact the Firm if You Lost Money

Aldeyra Therapeutics: A Mispriced Gem With Reproxalap's CRL Creating A Golden Buying Opportunity

Apr 21, 2025, 10:52 AM EDT - 3 months ago

Aldeyra Therapeutics: A Mispriced Gem With Reproxalap's CRL Creating A Golden Buying Opportunity

ALDX LEGAL REMINDER: Did Aldeyra Therapeutics, Inc. Commit Securities Violations? Contact BFA Law (NASDAQ:ALDX)

Apr 21, 2025, 8:33 AM EDT - 3 months ago

ALDX LEGAL REMINDER: Did Aldeyra Therapeutics, Inc. Commit Securities Violations? Contact BFA Law (NASDAQ:ALDX)

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Shareholders to Learn More About the Investigation

Apr 18, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Shareholders to Learn More About the Investigation

Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 17, 2025, 10:00 AM EDT - 4 months ago

Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

ALDX INVESTOR INVESTIGATION: Aldeyra Therapeutics, Inc. Investors are Reminded of the Ongoing Securities Investigation – Contact BFA Law (NASDAQ:ALDX)

Apr 17, 2025, 8:36 AM EDT - 4 months ago

ALDX INVESTOR INVESTIGATION: Aldeyra Therapeutics, Inc. Investors are Reminded of the Ongoing Securities Investigation – Contact BFA Law (NASDAQ:ALDX)

Aldeyra Therapeutics Appoints Chip Clark to Board of Directors

Apr 17, 2025, 7:00 AM EDT - 4 months ago

Aldeyra Therapeutics Appoints Chip Clark to Board of Directors

ALDX INVESTIGATION REMINDER: Aldeyra Therapeutics, Inc. Investors are Reminded of the Pending Investigation -- Contact BFA Law

Apr 16, 2025, 4:07 PM EDT - 4 months ago

ALDX INVESTIGATION REMINDER: Aldeyra Therapeutics, Inc. Investors are Reminded of the Pending Investigation -- Contact BFA Law

Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Shareholders to Inquire about Securities Investigation

Apr 16, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Shareholders to Inquire about Securities Investigation

ALDX INVESTIGATION: The Aldeyra Therapeutics, Inc. Securities Investigation is Ongoing - Contact BFA Law if You Suffered Losses

Apr 15, 2025, 3:36 PM EDT - 4 months ago

ALDX INVESTIGATION: The Aldeyra Therapeutics, Inc. Securities Investigation is Ongoing - Contact BFA Law if You Suffered Losses

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Connect

Apr 15, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Connect

ALDX INVESTIGATION NOTICE: Suffer Losses on Aldeyra Therapeutics, Inc.? Contact BFA Law about the Securities Investigation (NASDAQ:ALDX)

Apr 15, 2025, 8:18 AM EDT - 4 months ago

ALDX INVESTIGATION NOTICE: Suffer Losses on Aldeyra Therapeutics, Inc.? Contact BFA Law about the Securities Investigation (NASDAQ:ALDX)

Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Stockholders to Inquire about Securities Investigation

Apr 14, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation

Apr 13, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation

PeterV9764
PeterV9764 Aug. 7 at 11:28 PM
$ALDX No shares sold …
1 · Reply
All4Retiring
All4Retiring Aug. 7 at 8:09 PM
$ALDX quarterly report for Aldeyra on the IR website Form 10-Q Filing Date August 7, 2025 Document Date June 30, 2025 Form Description Quarterly report which provides a continuing view of a company's financial position Filing Group Quarterly Filings Company Aldeyra Therapeutics, Inc. Issuer ALDEYRA THERAPEUTICS, INC.
0 · Reply
ktrader1991
ktrader1991 Aug. 7 at 5:41 PM
$ALDX we need the other 2 phase 2 trials to be released and successful. Come on Todd bring her home.
1 · Reply
Moneymachineuser
Moneymachineuser Aug. 7 at 3:34 PM
$ALDX completely normal today, buy the dip! ☺️
0 · Reply
All4Retiring
All4Retiring Aug. 7 at 2:01 PM
$ALDX FYI https://www.ladbible.com/news/world-news/chikungunya-virus-china-outbreak-134428-20250805
1 · Reply
Bigbas
Bigbas Aug. 7 at 12:43 PM
$ALDX LEG DAY!!!
1 · Reply
TampaTony
TampaTony Aug. 6 at 8:22 PM
$ALDX Montana, any 25k buys today?
1 · Reply
MontanaT
MontanaT Aug. 6 at 4:55 PM
$ALDX
0 · Reply
MontanaT
MontanaT Aug. 6 at 4:52 PM
$ALDX
0 · Reply
Moneymachineuser
Moneymachineuser Aug. 6 at 3:59 PM
$ALDX 1400 shares added today, wishing everyone the best here!!!😇
0 · Reply
Milanfinest
Milanfinest Aug. 6 at 2:39 PM
$ALDX buy now or cry later
0 · Reply
All4Retiring
All4Retiring Aug. 6 at 11:05 AM
$ALDX https://ir.aldeyra.com/news-releases/news-release-details/aldeyra-therapeutics-participate-hc-wainwright-5th-annual
0 · Reply
All4Retiring
All4Retiring Aug. 6 at 11:05 AM
$ALDX August 6, 2025 7:01 AM EDT Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
0 · Reply
Moneymachineuser
Moneymachineuser Aug. 6 at 1:00 AM
$ALDX seems to be getting spicy in here with these mysterious 25k share buys weve been seeing over the course of a week.
1 · Reply
Tgk11
Tgk11 Aug. 5 at 6:57 PM
$ALDX In the next couple of months, the market usually struggles To stay above water. Let's see how the price of this does.
1 · Reply
MontanaT
MontanaT Aug. 5 at 4:48 PM
$ALDX LFG GANG, we gonna rip hard!!!!! Soon!!!
0 · Reply
MontanaT
MontanaT Aug. 5 at 4:47 PM
$ALDX something definitely leaked…
0 · Reply
MontanaT
MontanaT Aug. 5 at 4:44 PM
$ALDX bruh again…
2 · Reply
MontanaT
MontanaT Aug. 5 at 4:05 PM
$ALDX back to 7.2 then 11.97 ; )
0 · Reply
Bigbas
Bigbas Aug. 5 at 1:20 PM
$ALDX we’ve stretched now it’s time to pump them legs!! LFG!! Keeping it clean for my boy @Aidsg
2 · Reply
Milanfinest
Milanfinest Aug. 5 at 10:23 AM
$ALDX we are here for the fireworks
0 · Reply
MontanaT
MontanaT Aug. 5 at 8:42 AM
$ALDX
1 · Reply